Pfizer and BioNTech's Coronavirus Vaccine Approved in Canada

On Tuesday, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) won another crucial approval from a major healthcare regulator for their coronavirus vaccine. Health Canada authorized the two companies' BNT162b2 for widespread and general use, writing that it meets the "stringent safety, efficacy and quality requirements for use in Canada."